Roundtable Discussion: Can Models Predict Efficacy?

Time: 12:50 pm
day: Day Two


Join in the conversation with this discussion dedicated to the accurate modelling of efficacy at preclinical and translational stages. Share with and learn from your peers as we look into the current models for efficacy modelling and the potential of new 3D models:

  • Advantages and disadvantages of available models
  • How do we model tumour antigen specificity?
  • Ex vivo human tumoroid models; can they fill the gap?